Dec. 20, 2018:
In this month’s Across the Consortium, we are inspired by Big Ten cancer researchers making significant discoveries in improving treatment and quality of life for cancer patients. We also recognize those who have received grants for their work.
Dec. 1, 2018: Investigator Spotlight Pavankumar Tandra, MBBS, Fred & Pamela Buffett Cancer Center (University of Nebraska) Educational background MBBS: Osmania Medical School MRCGP: South East Scotland Deanery Fellowship (Hematology-Oncology): University of Nebraska Medical Center Research interests My research interests include tailoring the systemic therapies for early stage HER2-positive breast cancer. I believe we should do more studies in the neoadjuvant platform to assess the strengths of new targeted drugs, to identify biomarkers and minimize the toxicity from chemotherapy. It is very promising to see the new drugs studied...
Nov. 20, 2018: Kari Wisinski, MD, a breast cancer specialist with the UW Carbone Cancer Center, has been named to the Steering Committee of the Big Ten Cancer Research Consortium (Big Ten CRC). In that role, she will serve as the University of Wisconsin-Madison representative, helping shape the research priorities of the Big Ten CRC. She currently is the co-chair of the consortium's Breast Cancer Clinical Trial Working Group. Read More
Rutgers trial aims to demonstrate reduction in immune-related adverse events, while adding to anti-cancer immune effects for patients Nov. 15, 2018: BeyondSpring Inc. recently announced the opening of an investigator-initiated Phase 1 clinical trial with a triple combination therapy, consisting of BeyondSpring’s lead asset, plinabulin, and Bristol-Myers Squibb's Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment of small-cell lung cancer (SCLC). The trial (BTCRC-LUN17-127), conducted through the Big Ten Cancer Research Consortium (Big Ten CRC), is currently enrolling subjects at Rutgers Cancer Institute of New Jersey. Jyoti Malhotra, MD, MPH, medical...
Nov. 12, 2018: In this month's Across the Consortium, we focus on strategies Big Ten cancer centers are using to assist those who have difficulty finding resources for their cancer treatment or prevention. We also highlight some recent discoveries in several cancer types. Read More
Nov. 1, 2018: The Robert H. Lurie Comprehensive Cancer Center of Northwestern University (cancer.northwestern.edu), one of only 49 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers in the nation, is dedicated to scientific discovery, advancing medical knowledge, providing compassionate, state-of-the-art cancer care, and training the next generation of clinicians and scientists. Outstanding basic, translational, and clinical research complements a full range of prevention, early detection, treatment, rehabilitation, and palliative care programs for all types of cancer. Read More
Oct. 23, 2018: In this month's Across the Consortium, we highlight the innovative work of our member cancer centers across a wide spectrum of cancer care: from prevention to new approaches to treatment, from bench science to survivorship. Catch the latest from each member cancer center in this month's edition. Read More
Oct. 23, 2018: Big Ten investigators presented Phase Ib results of the BTCRC-LUN15-017 study during a poster session at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer, Sept. 23-26 in Toronto. Read More
Oct. 22, 2018: Applications are now open for a nationwide integrative oncology training program. The Integrative Oncology (IO) Scholars program brings together oncology professionals in a free year-long course. Designed for the full spectrum of oncology care professionals, the program equips oncologists, nurses, physicians assistants, physical and occupational therapists, social workers, and psychologists with the knowledge and skills necessary to provide safe and evidence-based integration of complementary therapies in conventional oncology care. The course is funded by the National Cancer Institute and developed by researchers and clinicians at the University of Michigan (U-M) Medical School.
Oct. 1, 2018: Investigator Spotlight Borys Hrinczenko, MD, PhD, Breslin Cancer Center at Michigan State University Educational background MD: SUNY Downstate College of Medicine, Brooklyn, NY PhD: University of Kansas, Lawrence, KS Internship and Residency: Mayo Clinic, Rochester, MN Fellowship: National Institutes of Health, Bethesda, MD Research interests My main interest is in new therapies for lung cancer, including the use of immune checkpoint inhibitors, the same treatments for which James P. Allison and Tasuku Honjo were awarded the 2018 Nobel Prize in Medicine. At the Breslin Cancer Center, we have Phase I clinical trials using...
University of Illinois
Indiana University
University of Iowa
University of Maryland
University of Michigan
Michigan State
University of Minnesota
University of Nebraska
Northwestern University
Penn State University
Purdue University
Rutgers State University
University of Wisconsin
University of Illinois at Chicago
© 2024 All rights reserved.
Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube